(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
0.42% ¥ 475.00
Live Chart Being Loaded With Signals
StemRIM, a biotechnology company, develops regeneration medicines for the treatment of intractable diseases. It develops PJ1, a regeneration induction medicine HMGB1 peptides, which is in Phase II clinical trials for the treatment of epidermolysis bullosa, cerebral infarction, osteoarthritis, and chronic liver disease, as well as cardiomyopathy; PJ2, a regeneration-inducing medicine novel peptides A and B; PJ3, a biologic regeneration-inducing protein; PJ4, an autologous cell sampling device for medical treatment; and PJ5, a stem cell gene therapy...
Stats | |
---|---|
Volumen de hoy | 177 500 |
Volumen promedio | 263 768 |
Capitalización de mercado | 29.21B |
EPS | ¥0 ( 2024-03-12 ) |
Próxima fecha de ganancias | ( ¥0 ) 2024-06-11 |
Last Dividend | ¥0 ( N/A ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 144.82 |
ATR14 | ¥0.592 (0.12%) |
Volumen Correlación
StemRIM Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
StemRIM Correlación - Moneda/Commodity
StemRIM Finanzas
Annual | 2023 |
Ingresos: | ¥2.35B |
Beneficio Bruto: | ¥2.30B (97.97 %) |
EPS: | ¥2.80 |
FY | 2023 |
Ingresos: | ¥2.35B |
Beneficio Bruto: | ¥2.30B (97.97 %) |
EPS: | ¥2.80 |
FY | 2022 |
Ingresos: | ¥22.98M |
Beneficio Bruto: | ¥22.98M (100.00 %) |
EPS: | ¥-32.92 |
FY | 2021 |
Ingresos: | ¥1.40B |
Beneficio Bruto: | ¥0.00 (0.00 %) |
EPS: | ¥-10.78 |
Financial Reports:
No articles found.
StemRIM
StemRIM, a biotechnology company, develops regeneration medicines for the treatment of intractable diseases. It develops PJ1, a regeneration induction medicine HMGB1 peptides, which is in Phase II clinical trials for the treatment of epidermolysis bullosa, cerebral infarction, osteoarthritis, and chronic liver disease, as well as cardiomyopathy; PJ2, a regeneration-inducing medicine novel peptides A and B; PJ3, a biologic regeneration-inducing protein; PJ4, an autologous cell sampling device for medical treatment; and PJ5, a stem cell gene therapy. StemRIM was incorporated in 2006 and is based in Ibaraki, Japan.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico